Want to see ACHC full AI Analyst Report?
ACHC Stock Chart & Stats
$29.87
$0.50(1.47%)
At close: 4:00 PM EDT
$29.87
$0.50(1.47%)
Day’s Range― - ―
52-Week Range$11.43 - $35.83
Previous Close$34.51
Volume2.30M
Average Volume (3M)2.19M
Market Cap
$2.62B
Enterprise Value$5.30K
Total Cash (Recent Filing)$171.29M
Total Debt (Recent Filing)$2.56B
Price to Earnings (P/E)―
Beta0.65
Next Earnings
Nov 04, 2026EPS Estimate
0.47Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.45
Shares Outstanding93,100,270
10 Day Avg. Volume1,476,065
30 Day Avg. Volume2,193,443
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.66
Price to Sales (P/S)0.39
P/FCF Ratio-2.93
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$32.50Price Target Upside8.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)1.53
Revenue Forecast (FY)$3.43B
Bulls Say, Bears Say
Bulls Say
Underlying Revenue GrowthReported revenue was affected by prior-period supplemental payments, but normalized growth remained positive. This indicates continued underlying demand and provides a more durable base for recovery as temporary payment comparisons normalize.
Capacity ExpansionAdding licensed beds and facilities expands treatment capacity and future revenue potential in behavioral healthcare. Joint ventures may also support growth while sharing investment and operational requirements with partners.
Positive Operating Cash FlowPositive and improving operating cash flow shows that the core service network is generating cash despite reported losses. Sustained operating cash generation could help fund expansion and reduce dependence on external financing over time.
Bears Say
Deep Profitability DeteriorationThe sharp shift from profitability in 2024 to a substantial TTM loss signals weakened and volatile earnings power. Persistent losses could constrain reinvestment, increase financing needs, and make operational recovery more difficult.
Higher LeverageThe rise in debt relative to equity reduces financial flexibility while earnings are under pressure. Higher leverage can limit Acadia’s ability to absorb operating setbacks or invest aggressively in beds, facilities, and service expansion.
Weak Free Cash Flow ConversionAlthough operating cash flow is positive, ongoing negative free cash flow shows that capital demands still exceed internally generated cash. Continued weak conversion could require financing and restrict the company’s ability to delever.
Acadia Healthcare News
ACHC FAQ
What was Acadia Healthcare’s price range in the past 12 months?
Acadia Healthcare lowest stock price was $11.43 and its highest was $35.83 in the past 12 months.
What is Acadia Healthcare’s market cap?
Acadia Healthcare’s market cap is $2.62B.
When is Acadia Healthcare’s upcoming earnings report date?
Acadia Healthcare’s upcoming earnings report date is Nov 04, 2026 which is in 58 days.
How were Acadia Healthcare’s earnings last quarter?
Acadia Healthcare released its earnings results on Jul 28, 2026. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.346 by $0.034.
Is Acadia Healthcare overvalued?
According to Wall Street analysts Acadia Healthcare’s price is currently Undervalued.
Does Acadia Healthcare pay dividends?
Acadia Healthcare does not currently pay dividends.
What is Acadia Healthcare’s EPS estimate?
Acadia Healthcare’s EPS estimate is 0.47.
How many shares outstanding does Acadia Healthcare have?
Acadia Healthcare has 93,100,270 shares outstanding.
What happened to Acadia Healthcare’s price movement after its last earnings report?
Acadia Healthcare reported an EPS of $0.38 in its last earnings report, beating expectations of $0.346. Following the earnings report the stock price went down -16.335%.
Which hedge fund is a major shareholder of Acadia Healthcare?
Currently, no hedge funds are holding shares in ACHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Acadia Healthcare Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$32.50 (8.80% Upside)
$32.50 (8.80% Upside)
Blogger Sentiment
Bullish
ACHC Sentiment 71%
Sector Average 60%
Sector Average 60%
Hedge Fund Trend
Increased
By 545.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.7%
Last 30 Days ▲ 1.3%
Last 30 Days ▲ 1.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.94%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-12.08%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Acadia Healthcare
Acadia Healthcare Company, Inc. specializes in delivering a comprehensive range of behavioral health services, with its operations spanning the United States and Puerto Rico. Patients receive care in diverse environments, including acute inpatient psychiatric hospitals, specialized treatment facilities, long-term residential centers, and outpatient clinics. As of March 31, 2022, the company managed an extensive network consisting of 238 behavioral healthcare facilities, collectively providing approximately 10,600 beds. Established in 2005, Acadia Healthcare is headquartered in Franklin, Tennessee.
ACHC Company Deck
ACHC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a constructive operational and financial start to 2026: revenue and adjusted EBITDA grew, results beat guidance, management raised full-year profitability targets, and execution initiatives (leadership changes, cost efficiencies, bed additions, JVs, technology) are showing early benefits. Offsetting these positives are persistent challenges in specialty (notably Pennsylvania), slower CTC performance due to weather, elevated bad debts/denials, temporary higher leverage in Q2 from timing of supplemental payments, and ongoing start-up/closure headwinds. Overall, progress on operations and margins appears to outweigh the headwinds, though some risks (payer behavior and supplemental approvals) remain.View all ACHC earnings summariesACHC Stock 12 Month Forecast
Average Price Target
$32.50
▲(8.80% Upside)
Technical Analysis
Brookdale Senior Living
―
National Healthcare
―
―
Surgery Partners
―
Lifestance Health Group
―
Ownership Overview
2.18% Insiders
28.37% Mutual Funds
6.90% Other Institutional Investors
28.18% Public Companies and
Individual Investors